BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26949001)

  • 1. Invasive fungal diseases in patients with acute lymphoid leukemia.
    Nicolato A; Nouér SA; Garnica M; Portugal R; Maiolino A; Nucci M
    Leuk Lymphoma; 2016 Sep; 57(9):2084-9. PubMed ID: 26949001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary antifungal prophylaxis in adult patients with acute lymphoblastic leukaemia: a multicentre audit.
    Doan TN; Kirkpatrick CM; Walker P; Slavin MA; Ananda-Rajah MR; Morrissey CO; Urbancic KF; Grigg A; Spencer A; Szer J; Seymour JF; Kong DC
    J Antimicrob Chemother; 2016 Feb; 71(2):497-505. PubMed ID: 26518050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive fungal disease in pediatric acute leukemia patients with fever and neutropenia during induction chemotherapy: a multivariate analysis of risk factors.
    Wiley JM; Smith N; Leventhal BG; Graham ML; Strauss LC; Hurwitz CA; Modlin J; Mellits D; Baumgardner R; Corden BJ
    J Clin Oncol; 1990 Feb; 8(2):280-6. PubMed ID: 2299371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary antifungal prophylaxis: decrease of invasive fungal disease incidence and reduction of risk factors in haematological patients in a 5-year retrospective study.
    Li Y; Liu M; Zhai B; Zhao X; Wang L; Li H; Wang S; Zhu H; Wang Q; Gao C; Huang W; Yu L
    Intern Med J; 2018 Jun; 48(6):713-720. PubMed ID: 29230923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and risk factors of post-engraftment invasive fungal disease in adult allogeneic hematopoietic stem cell transplant recipients receiving oral azoles prophylaxis.
    Montesinos P; Rodríguez-Veiga R; Boluda B; Martínez-Cuadrón D; Cano I; Lancharro A; Sanz J; Arilla MJ; López-Chuliá F; Navarro I; Lorenzo I; Salavert M; Pemán J; Calvillo P; Martínez J; Carpio N; Jarque I; Sanz GF; Sanz MA
    Bone Marrow Transplant; 2015 Nov; 50(11):1465-72. PubMed ID: 26281032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
    Sun Y; Meng F; Han M; Zhang X; Yu L; Huang H; Wu D; Ren H; Wang C; Shen Z; Ji Y; Huang X
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary fungal prophylaxis in acute leukemia patients with different risk factors: retrospective analysis from the CAESAR study.
    Zhang R; Chen J; Huang H; Ma J; Meng F; Tang Y; Hu J; Zhang X; Ji Y; Ai H; Liang Y; Wu D; Huang X; Han M
    Int J Hematol; 2017 Aug; 106(2):221-228. PubMed ID: 28390035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: a 4-year study.
    Lerolle N; Raffoux E; Socie G; Touratier S; Sauvageon H; Porcher R; Bretagne S; Bergeron A; Azoulay E; Molina JM; Lafaurie M
    Clin Microbiol Infect; 2014 Nov; 20(11):O952-9. PubMed ID: 24861577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proven and probable invasive fungal infections in children with acute lymphoblastic leukaemia: results from an university hospital, 2005-2013.
    Sahbudak Bal Z; Yilmaz Karapinar D; Karadas N; Sen S; Onder Sivis Z; Akinci AB; Balkan C; Kavakli K; Vardar F; Aydinok Y
    Mycoses; 2015 Apr; 58(4):225-32. PubMed ID: 25728069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of hospital construction with the development of healthcare associated environmental mold infections (HAEMI) in pediatric patients with leukemia.
    Pokala HR; Leonard D; Cox J; Metcalf P; McClay J; Siegel J; Winick N
    Pediatr Blood Cancer; 2014 Feb; 61(2):276-80. PubMed ID: 23970381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia.
    Cornely OA; Leguay T; Maertens J; Vehreschild MJGT; Anagnostopoulos A; Castagnola C; Verga L; Rieger C; Kondakci M; Härter G; Duarte RF; Allione B; Cordonnier C; Heussel CP; Morrissey CO; Agrawal SG; Donnelly JP; Bresnik M; Hawkins MJ; Garner W; Gökbuget N;
    J Antimicrob Chemother; 2017 Aug; 72(8):2359-2367. PubMed ID: 28575414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary antifungal prophylaxis in hematological malignancy patients with previous invasive fungal disease: a retrospective analysis.
    Liu M; Li Y; Zhang Y; Zhao X; Zhai B; Zhang Q; Wang L; Zhao Y; Li H; Wang Q; Gao C; Huang W; Yu L
    PLoS One; 2014; 9(12):e115461. PubMed ID: 25531544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and characteristics of invasive fungal diseases in allogeneic hematopoietic stem cell transplant recipients: a retrospective cohort study.
    Harrison N; Mitterbauer M; Tobudic S; Kalhs P; Rabitsch W; Greinix H; Burgmann H; Willinger B; Presterl E; Forstner C
    BMC Infect Dis; 2015 Dec; 15():584. PubMed ID: 26715563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive fungal diseases in patients with new diagnosed acute lymphoblastic leukaemia.
    Gründahl M; Wacker B; Einsele H; Heinz WJ
    Mycoses; 2020 Oct; 63(10):1101-1106. PubMed ID: 32738006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: a retrospective, observational, sequential cohort analysis.
    Kubiak DW; Bryar JM; McDonnell AM; Delgado-Flores JO; Mui E; Baden LR; Marty FM
    Clin Ther; 2010 Apr; 32(4):637-48. PubMed ID: 20435233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive fungal diseases impact on outcome of childhood ALL - an analysis of the international trial AIEOP-BFM ALL 2009.
    Lehrnbecher T; Groll AH; Cesaro S; Alten J; Attarbaschi A; Barbaric D; Bodmer N; Conter V; Izraeli S; Mann G; Möricke A; Niggli F; Schrappe M; Stary J; Zapotocka E; Zimmermann M; Elitzur S
    Leukemia; 2023 Jan; 37(1):72-78. PubMed ID: 36509893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential low-dose CT thorax scans to determine invasive pulmonary fungal infection incidence after allogeneic hematopoietic cell transplantation.
    Enger K; Tonnar X; Kotter E; Bertz H
    Ann Hematol; 2023 Feb; 102(2):413-420. PubMed ID: 36460795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility and effectiveness of posaconazole prophylaxis in combination with micafungin bridging for patients undergoing allogeneic stem cell transplantation: a 6-yr analysis from the cologne cohort for neutropenic patients.
    Vehreschild MJ; von Bergwelt-Baildon M; Tran L; Shimabukuro-Vornhagen A; Wisplinghoff H; Bangard C; Cornely OA; Vehreschild JJ
    Eur J Haematol; 2014 Nov; 93(5):400-6. PubMed ID: 24798021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for invasive fungal disease after allogeneic hematopoietic stem cell transplantation: a single center experience.
    Omer AK; Ziakas PD; Anagnostou T; Coughlin E; Kourkoumpetis T; McAfee SL; Dey BR; Attar E; Chen YB; Spitzer TR; Mylonakis E; Ballen KK
    Biol Blood Marrow Transplant; 2013 Aug; 19(8):1190-6. PubMed ID: 23747459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Retrospective Analysis of Invasive Fungal Diseases (IFD) of the Central Nervous System in Children With Lymphoid Malignancies.
    Ramanathan S; Kate S; Kembhavi S; Cheriyalinkal Parambil B; K C A; Bhat V; Prasad M; Moiyadi A; Biswas S; Narula G; Banavali S
    J Pediatr Hematol Oncol; 2020 May; 42(4):e202-e206. PubMed ID: 31815886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.